There is a seismic shift underway in science and medicine.
Cutting-edge technologies are changing the face of clinical trials and scientiic research. New therapeutics and vaccines are being developed at an unprecedented pace. Algorithms are increasingly being used to guide the care of patients around the globe.
Those breakthroughs — and the challenges ahead for scientiic institutions and health care systems — were center stage at the 2021 STAT Summit. The event featured perspective from biotech visionaries like George Church, top executives at GlaxoSmithKline and Verily, and the minds behind the Biden administration’s ARPA-H program. It also looked deeply at both the crisis of Black maternal mortality in the U.S., the future of treatment for Alzheimer’s disease, and the next stage of drug pricing legislation in Congress.
These stories, taken together, underscore the important conversations happening as researchers, health care industry leaders, and policymakers navigate the future of science and medicine.